MedPath

The lowering effect of rose hip-derived tiliroside on the body mass index (BMI) - A systematic review

Not Applicable
Conditions
Healthy adult volunteers
Registration Number
JPRN-UMIN000042339
Lead Sponsor
Morishita Jintan Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

The literature which does not meet the key inclusion criteria, proceedings, and unpublished studies will be excluded.

Study & Design

Study Type
Others,meta-analysis etc
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body mass index (BMI) Body fat (abdominal total fat area, abdominal subcutaneous fat area, abdominal visceral fat area)
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath